Skip to content
  • 6,949 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Presolicitation

LAB TESTING FOR CUSTOM MONOCLONAL RECOMBINANT ANTIBODIES GENERATED THROUGH HUCAL TECHNOLOGY (AMBIS 2222834)

NOI-NIAID-24-2222834

National Institutes of Health, National Institutes of Health Niaid. Testing Laboratories and Services.

Awarded

BIO-RAD Abd Serotec GMBH

$38,454.00 obligated so far on USAspending

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one was awarded in 2024

23 like it are open now in testing laboratories and services

All 23 open in testing laboratories and services

Description

As published on SAM.gov.

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Bio-Rad AbD Serotec GmbH, Campus Neuried, Anna-Sigmund-Str. 5, 82061, Neuried, Germany, to procure lab testing services for custom monoclonal recombinant antibodies generated through HuCAL technology.

The lab will send samples to the vendor, testing against the patented technology, and results will be provided. The purpose of this procurement is for lab testing services.

Lab synthesized antibodies will be sent to Bio-Rad, who will generate monoclonal recombinant antibodies through a patented technology, Human Combinatorial Antibody Libraries (HuCAL), a technology which Bio-Rad custom antibody generation service uses for the in vitro generation of highly specific, fully human, recombinant monoclonal antibodies in Fab and full immunoglobulin format. The lab will use these antibodies for in vitro studies including IHC (immunohistochemistry) studies.

Our lab will be sending lab-synthesized/lab-developed antigens to the antibody manufacturer. With the antigens, the antibody manufacturer will generate monoclonal recombinant antibodies and send it back to us. These antibodies will be used in our lab for in-vitro studies: CAB11586 - FAB PACKAGE, Antibody selection using a single customer provided antigen QC by specificity ELISA with purified antibodies, Delivery of 500 µI (~100-250 µg) each of all unique ELISA positive, purified Fab antibodies (max.

20), qty 1 CAB11447 - SPECIAL PROJECT, Competition Primary Screen, quantity 1 CAB11447 - SPECIAL PROJECT, Competition QC ELISA (Final QC), quantity 1 CAB11577 - INHIBITION ELISA (with Titration), quantity 1 CAB11447 - SPECIAL PROJECT, Handling of toxins, quantity 1 CAB11631 - FCCATCHER COUPLING MULTIPLE FABS FcCatcher Coupling Multiple - up to 20 Antibodies, -100-250 ug each; (includes Fab production) (for sco), quantity 1 CAB11664 - CATCHER FLUORESCENT FAB, Fluorescent Coupling Catchers max 250 ug, quantity 1 CAB11457 - SHIPPING AND HANDLING (USA), quantity 1 Only one award will be made as a result of this solicitation. This will be awarded as a firm-fixed price type of contract.

Delivery: Immediate, 3 months lead time Delivery location: Service shall be performed at the following location: NIH/NIAID/LCIM, 33 North Drive, Bethesda, MD 20892. The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS.

All responsible sources that could provide the required services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-24-2222834 to Rita Davis at rita.davis@nih.gov, by 4:00pm eastern standard time Tuesday, May 28, 2024. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
MWPKHDKYNKM3
CAGE
CK802
Vendor location
Neuried
Contract
75N93024P00693, purchase order
Obligated
$38,454.00
Actions
1 between May 31, 2024 and May 31, 2024
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Lab Testing Services for Custom Monoclonal Recombinant Antibodies Generated Through Hucal Technology (Ambis #2222834)
Match
solicitation number NOINIAID242222834 equals the FPDS solicitation identifier; same awarding office 75N930 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 16, 2024

    Presolicitation

    Due May 28, 2024 at 4:00 PM EDT. SAM.gov, notice f7d30b3b2c564437bc8200b9b01259f6

Points of contact